Krystal Biotech Inc (KRYS)
159.99
-1.61
(-1.00%)
USD |
NASDAQ |
May 31, 16:00
160.02
+0.02
(+0.02%)
After-Hours: 20:00
Krystal Biotech Shareholders Equity (Quarterly): 799.24M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 799.24M |
December 31, 2023 | 778.64M |
September 30, 2023 | 755.95M |
June 30, 2023 | 653.11M |
March 31, 2023 | 489.57M |
December 31, 2022 | 522.23M |
September 30, 2022 | 540.77M |
June 30, 2022 | 559.18M |
March 31, 2022 | 548.55M |
December 31, 2021 | 593.58M |
September 30, 2021 | 408.24M |
June 30, 2021 | 418.54M |
March 31, 2021 | 430.65M |
December 31, 2020 | 292.08M |
September 30, 2020 | 301.72M |
Date | Value |
---|---|
June 30, 2020 | 309.70M |
March 31, 2020 | 198.37M |
December 31, 2019 | 202.91M |
September 30, 2019 | 207.65M |
June 30, 2019 | 198.29M |
March 31, 2019 | 109.49M |
December 31, 2018 | 113.23M |
September 30, 2018 | 52.29M |
June 30, 2018 | 45.27M |
March 31, 2018 | 47.40M |
December 31, 2017 | 49.47M |
September 30, 2017 | 50.20M |
June 30, 2017 | 3.393M |
December 31, 2016 | 0.289M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
198.29M
Minimum
Jun 2019
799.24M
Maximum
Mar 2024
460.45M
Average
460.11M
Median
Shareholders Equity (Quarterly) Benchmarks
Axsome Therapeutics Inc | 144.04M |
Madrigal Pharmaceuticals Inc | 850.76M |
Alnylam Pharmaceuticals Inc | -219.27M |
Catalyst Pharmaceuticals Inc | 561.41M |
Cytokinetics Inc | -396.16M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 853.30M |
Total Liabilities (Quarterly) | 54.05M |
Current Ratio | 12.66 |